SCHEMBL21688034

SCHEMBL21688034

N#Cc1ccc2c(c1)c1ccccc1n2-c1ccc(-c2cccc([Si](c3ccccc3)(c3ccccc3)c3ccccc3C#N)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 3/20 0.32
LMNA P02545 2/20 0.32
MAPK1 P28482 2/20 0.32
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PTGER4 P35408 1/20 0.32
ALDH1A3 P47895 1/20 0.31
RARG P13631 1/20 0.31
MEN1 O00255 2/20 0.31
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 2/20 0.31
CYP2C19 P33261 2/20 0.31
KMT2A Q03164 2/20 0.31
CLK4 Q9HAZ1 2/20 0.31
PGR P06401 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687993 0.97 SMN1; SMN2 (0.34) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL21688166 0.94 KDM4E (0.35) KDM4EATML3MBTL1ALDH1A1LMNA
SCHEMBL21687500 0.93 KDM4E (0.33) KDM4EATML3MBTL1ALDH1A1LMNA
SCHEMBL21688085 0.93 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1LMNA
SCHEMBL21688027 0.92 KDM4E (0.33) KDM4EATML3MBTL1ALDH1A1LMNA
SCHEMBL21687990 0.91 ALDH1A1 (0.34) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL21687619 0.91 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1LMNA
SCHEMBL21687470 0.90 SMN1; SMN2 (0.34) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL21687483 0.90 KDM4E (0.35) KDM4EATML3MBTL1ALDH1A1LMNA
SCHEMBL21688013 0.90 KDM4E (0.35) KDM4EATML3MBTL1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 KDM4E 2977/4885ATM 1151/4885L3MBTL1 1003/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 KDM4E 2977/4885ATM 1151/4885L3MBTL1 1003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.